Key Points
- Kang Sun, an Amprius director, sold 1,500,000 shares on April 1 at an average price of $15.91 (≈$23.87M), cutting his ownership by 52.77% to 1,342,400 shares valued at about $21.36M.
- Amprius beat quarterly estimates with a ($0.01) EPS vs. consensus ($0.04) loss and $25.23M revenue, and analysts are mostly bullish (8 Buys, 1 Sell) with an average price target of $19.75 while the stock trades around $16.01 (market cap ≈ $2.19B).
Amprius Technologies, Inc. (NYSE:AMPX - Get Free Report) Director Kang Sun sold 1,500,000 shares of the stock in a transaction that occurred on Wednesday, April 1st. The shares were sold at an average price of $15.91, for a total transaction of $23,865,000.00. Following the transaction, the director owned 1,342,400 shares in the company, valued at $21,357,584. The trade was a 52.77% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Kang Sun also recently made the following trade(s):
- On Monday, March 23rd, Kang Sun sold 217,869 shares of Amprius Technologies stock. The stock was sold at an average price of $18.80, for a total transaction of $4,095,937.20.
- On Monday, February 23rd, Kang Sun sold 61,251 shares of Amprius Technologies stock. The stock was sold at an average price of $10.16, for a total transaction of $622,310.16.
- On Friday, January 16th, Kang Sun sold 950,548 shares of Amprius Technologies stock. The shares were sold at an average price of $11.07, for a total transaction of $10,522,566.36.
- On Tuesday, January 20th, Kang Sun sold 43,185 shares of Amprius Technologies stock. The shares were sold at an average price of $11.03, for a total transaction of $476,330.55.
- On Monday, January 12th, Kang Sun sold 506,267 shares of Amprius Technologies stock. The shares were sold at an average price of $10.10, for a total transaction of $5,113,296.70.
Amprius Technologies Stock Up 3.1%
Shares of NYSE:AMPX opened at $16.01 on Friday. The stock has a market cap of $2.19 billion, a PE ratio of -47.08 and a beta of 2.20. The company's fifty day moving average is $13.92 and its 200 day moving average is $12.05. Amprius Technologies, Inc. has a 52 week low of $1.97 and a 52 week high of $19.76.
Amprius Technologies (NYSE:AMPX - Get Free Report) last posted its quarterly earnings results on Wednesday, March 4th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating the consensus estimate of ($0.04) by $0.03. Amprius Technologies had a negative net margin of 60.30% and a negative return on equity of 24.29%. The business had revenue of $25.23 million during the quarter, compared to analyst estimates of $22.91 million. Amprius Technologies has set its FY 2026 guidance at --0.060 EPS. Sell-side analysts anticipate that Amprius Technologies, Inc. will post -0.45 EPS for the current year.
Institutional Inflows and Outflows
A number of hedge funds and other institutional investors have recently made changes to their positions in the company. Alberta Investment Management Corp bought a new stake in shares of Amprius Technologies during the fourth quarter valued at approximately $1,001,000. Vident Advisory LLC bought a new position in Amprius Technologies in the fourth quarter worth $107,000. Summit Securities Group LLC bought a new position in Amprius Technologies in the fourth quarter worth $54,000. Numerai GP LLC lifted its position in Amprius Technologies by 29.1% during the fourth quarter. Numerai GP LLC now owns 96,209 shares of the company's stock valued at $759,000 after buying an additional 21,698 shares during the period. Finally, Osterweis Capital Management Inc. boosted its holdings in shares of Amprius Technologies by 142.6% during the 4th quarter. Osterweis Capital Management Inc. now owns 454,830 shares of the company's stock valued at $3,589,000 after buying an additional 267,385 shares in the last quarter. Hedge funds and other institutional investors own 5.04% of the company's stock.
Wall Street Analysts Forecast Growth
AMPX has been the topic of several recent research reports. William Blair restated an "outperform" rating on shares of Amprius Technologies in a research report on Friday, March 6th. Roth Mkm reissued a "buy" rating and set a $20.00 price objective (up from $16.00) on shares of Amprius Technologies in a research note on Friday, March 6th. Craig Hallum raised their target price on shares of Amprius Technologies from $17.00 to $21.00 and gave the stock a "buy" rating in a report on Friday, March 6th. Weiss Ratings reaffirmed a "sell (e+)" rating on shares of Amprius Technologies in a research note on Wednesday, January 21st. Finally, Cantor Fitzgerald upped their price target on shares of Amprius Technologies from $16.00 to $20.00 and gave the company an "overweight" rating in a report on Friday, March 6th. Eight investment analysts have rated the stock with a Buy rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, the company currently has an average rating of "Moderate Buy" and an average price target of $19.75.
Get Our Latest Research Report on AMPX
Amprius Technologies Company Profile
(
Get Free Report)
Amprius Technologies, Inc (NYSE: AMPX) is a U.S.-based developer of high-energy-density lithium-ion batteries that leverage silicon anode technology to deliver performance levels beyond conventional graphite-based cells. The company's batteries are designed to offer industry-leading gravimetric energy density, enabling longer run times and reduced weight for portable power applications. Amprius blends advanced materials science and scalable manufacturing processes to commercialize next-generation battery solutions.
At the core of Amprius' product portfolio are cylindrical and prismatic cells that employ a proprietary silicon nanowire anode, which supports high charge/discharge rates while maintaining cycle life.
Featured Stories
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. Please send any questions or comments about this story to [email protected].
